BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE capsule Amerika Serikat - Inggris - NLM (National Library of Medicine)

bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride capsule

ingenus pharmaceuticals, llc - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori  has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may

PINK BISMUTH CHEWABLE TABLETS Israel - Inggris - Ministry of Health

pink bismuth chewable tablets

perrigo israel agencies ltd, israel - bismuth subsalicylate - chewable tablets - bismuth subsalicylate 262 mg - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

PINK BISMUTH SUSPENSION Israel - Inggris - Ministry of Health

pink bismuth suspension

perrigo israel agencies ltd, israel - bismuth sub salicylate - suspension - bismuth sub salicylate 262.50 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

BISMUTH SUBSALICYLATE/METRONIDAZOLE/TETRACYCLINE HYDROCHLORIDE- bismuth subsalicylate chewable tablets/metronidazole tablets/tet Amerika Serikat - Inggris - NLM (National Library of Medicine)

bismuth subsalicylate/metronidazole/tetracycline hydrochloride- bismuth subsalicylate chewable tablets/metronidazole tablets/tet

ailex pharmaceuticals, llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - the components of bismuth subsalicylate chewable tablets/ metronidazole tablets/tetracycline hydrochloride capsules (bismuth subsalicylate, metronidazole, and tetracycline hydrochloride), in combination with an h2 antagonist, are indicated for the eradication of h. pylori for treatment of patients with h. pylori infection and duodenal ulcer disease (active or a history of duodenal ulcer). the eradication of h. pylori has been demonstrated to reduce the risk of duodenal ulcer recurrence in patients with active duodenal ulcer disease (see clinical studies and dosage and administration ). to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptib

PEPTOSYL BISMUTH SALICYLATE ORAL SUSPENSION Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

peptosyl bismuth salicylate oral suspension

ceva animal health pty ltd - bismuth subsalicylate - oral solution/suspension - bismuth subsalicylate mineral-bismuth active 17.5 mg/ml - alimentary system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - diarrhoea | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

PYLERA (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride- 140 mg/125 mg/125 mg capsule Amerika Serikat - Inggris - NLM (National Library of Medicine)

pylera (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride- 140 mg/125 mg/125 mg capsule

physicians total care, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth - unii:u015tt5i8h), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium 140 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to resu

Bismuth subnitrate and Iodoform paste Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

bismuth subnitrate and iodoform paste

a a h pharmaceuticals ltd - bismuth subnitrate; iodoform - cutaneous paste - 252mg/1gram ; 503mg/1gram

Boviseal 2.6 g Intramammary Suspension for Cattle (Dairy Cows) Inggris - Inggris - VMD (Veterinary Medicines Directorate)

boviseal 2.6 g intramammary suspension for cattle (dairy cows)

continental farmaceutica - bismuth subnitrate - intramammary suspension - miscellaneous mechanical teat seal - cattle

Fatroseal 2.6 g Intramammary Suspension for Dry Cows Inggris - Inggris - VMD (Veterinary Medicines Directorate)

fatroseal 2.6 g intramammary suspension for dry cows

support pharma s.l. - bismuth subnitrate - intramammary suspension - miscellaneous mechanical teat seal - cattle

Fatroseal 2.6 g Intramammary Suspension for Dry Cows Inggris - Inggris - VMD (Veterinary Medicines Directorate)

fatroseal 2.6 g intramammary suspension for dry cows

support pharma s.l. - bismuth subnitrate - intramammary suspension - miscellaneous mechanical teat seal - cattle